The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer
- 438 Downloads
The levels of expression of the four receptors and eleven ligands composing the epidermal growth factor family were measured using immunohistochemical staining in one hundred cases of breast cancer. All of the family were expressed to some degree in some cases; however, individual cases showed a very wide range of expression of the family from essentially none to all the factors at high levels. The highest aggregate level of expression of a receptor was HER2 followed by HER1, then HER3, then HER4. The ligands (including two splice variants of the NRG1 and NRG2 genes) broadly fell into three groups, those with the highest aggregate expression were Epigen, Epiregulin, Neuregulin 1α, Neuregulin 2α, Neuregulin 2β, Neuregulin 4 and TGFα, moderate expression was seen with EGF, Neuregulin 1β and Neuregulin 3, and relatively low levels of expression were seen of HB-EGF, Betacellulin and Amphiregulin. Statistical analysis using Spearman’s Rank Correlation showed a positive correlation of expression between each of the factors. Analysing the data using the Cox Proportional Hazards model showed that, in this dataset, the most powerful predictors of relapse free interval and overall survival were the combined measurement of only Epigen and Neuregulin 4.
KeywordsErbB Growth factor Growth factor receptor Prognosis Breast cancer
We are grateful to Professor Adrian Harris and Dr Russell Leek for the tissue array samples. Edith Blackburn is supported by a grant from the E. B. Hutchinson Trust.
- 4.Lemmon MA (2009) Ligand-induced receptor dimerisation. Exp Cell Res 315:638–648Google Scholar
- 7.Kochupurakkai BS, Harari D, Di-Segni A, Maik-Rachline G, Lyass L, Gur G, Kerber G, Citri A, Lavi S, Eilam R, Chalifa-Caspi V, Eshhar Z, Pikarsky E, Pinkas-Kramarski R, Bacuss SS, Yarden Y (2005) Epigen the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J Biol Chem 280:8503–8512CrossRefGoogle Scholar
- 11.Rajkumar T, Majhi U, Malligarjuna V, Shantha V, Gullick WJ (1995) Prevalence of c-erbB-3 expression in squamous cell carcinomas of the cervix as determined by the monoclonal antibody RTJ-2. Int J Oncol 6:105–109Google Scholar
- 16.Normanno N, Qi C-F, Gullick WJ, Persico G, Yarden Y, Wen D, Plowman G, Kenny N, Johnson G, Kim N, Brandt R, Soarez I, Dickson RB, Salomon DS (1993) Expression of Amphiregulin, cripto-1 and Heregulin alpha in human breast cancer cells. Int J Oncol 2:903–911Google Scholar